Share-Based Compensation (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of Share-based Compensation Expense

Stock-based compensation expense is included in the condensed consolidated statements of operations as follows:

	Nine Months Ended September 30,
	2023		2022
Payroll and related expenses	$	3,210,631	$	1,874,857
Total	$	3,210,631	$	1,874,857

	Three Months Ended September 30,
	2023		2022
Payroll and related expenses	$	—	$	594,694
Total	$	—	$	594,694

Stock-based compensation expense is included in the consolidated statements of operations as follows:

	Year Ended December 31,
	2022		2021
Payroll and related expenses	$	2,798,844	$	1,647,391
General and administrative expenses		—		—
Total	$	2,798,844	$	1,647,391

	Year Ended December 31,
	2022		2021
Stock options	$	—	$	2,666
RSUs		2,798,844		1,644,725
Total	$	2,798,844	$	1,647,391

Schedule of Stock-Based Option Activity

The following table summarizes stock-based option activities and changes during the nine months ended September 30, 2023 as described below:

	Shares		Weighted Average Fair Value Per Share		Weighted Average Exercise Price Per Share		Weighted Average Remaining Terms (in years)		Aggregate Intrinsic Value
Outstanding – December 31, 2022		36,436		24.80		78.71		4.34		—
Granted		—		—		—		—		—
Exercised		—		—		—		—		—
Cancelled		—		—		—		—		—
Outstanding – September 30, 2023		36,436		24.80		78.71		3.84		—
Exercisable – December 31, 2022		36,436		24.80		78.71		4.34		—
Exercisable – September 30, 2023		36,436		24.80		78.71		3.84		—

The following table summarizes stock-based option activities and changes during the years ended December 31, 2022 and 2021, as described below:

	Shares		Weighted Average Fair Value Per Share		Weighted Average Exercise Price Per Share		Weighted Average Remaining Terms (in years)		Aggregate Intrinsic Value
Outstanding – December 31, 2020		36,436	$	35.54	$	78.71		6.34	$	—
Granted		—		—		—
Exercised		—		—		—
Cancelled		—		—		—
Outstanding – December 31, 2021		36,436	$	24.80	$	78.71		5.34	$	—
Granted		—		—		—
Exercised		—		—		—
Cancelled		—		—		—
Outstanding – December 31, 2022		36,436		24.80		78.71		4.34	$	—
Exercisable – December 31, 2021		36,436		24.80		78.71		5.34		—
Exercisable – December 31, 2022		36,436	$	24.80	$	78.71		4.34	$	—

Schedule of Restricted Stock Unit

The following table summarized restricted stock unit activities during the nine months ended September 30, 2023:

	Number of Shares
Non-vested balance at January 1, 2023		1,190,935
Granted		585,000
Vested		(1,775,935	)
Forfeited/Expired		—
Non-vested balance at September 30, 2023		—

The following table summarized restricted stock unit activities during the year ended December 31, 2022:

	Number of Shares
Non-vested balance at January 1, 2022		1,274,137
Granted		1,125,000
Vested		(890,122	)
Forfeited/Expired		(125,118	)
Non-vested balance at December 31, 2022		1,383,897

Schedule of Stock-Based Compensation Expense by Security Type Included in the Condensed Consolidated Statements

The following table presents total stock-based compensation expense by security type included in the condensed consolidated statements of operations:

	Nine Months Ended September 30,
	2023		2022
Stock options	$	—	$	—
Restricted Stock Units	$	3,210,631	$	1,874,857
Total	$	3,210,631	$	1,874,857

	Three Months Ended September 30,
	2023		2022
Stock options	$	—	$	—
Restricted Stock Units	$	—	$	594,694
Total	$	—	$	594,694